Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors

Neoplasia

Volumn 7, Issue 2, 2005, Pages 109-117

  Cohen, Batya ^a   Dafni, Hagit ^a   Meir, Gila ^a   Harmelin, Alon ^a   Neeman, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

C6 glioma; Ferritin; Gene expression; Iron; MRI

Indexed keywords

CELL PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; FERRITIN; HEMAGGLUTININ; IRON; TETRACYCLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL SUSPENSION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXPRESSION VECTOR; FLUORESCENCE MICROSCOPY; GENE CONSTRUCT; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GLIOMA; HISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; IRON STORAGE; IRON TRANSPORT; MOLECULAR IMAGING; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN EXPRESSION; PROTEIN STABILITY; REPORTER GENE; VALIDATION PROCESS;

EID: 14644420216     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.04436     Document Type: Article

References (33)

1. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, and Li KC (1998). Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med 4, 623-626.
2. Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, and Basilion JP (2000). In vivo magnetic resonance imaging of transgene expression. Nat Med 6, 351-355.
3. Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, and Wickline SA (2003). Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3- integrin-targeted nanoparticles. Circulation 108, 2270-2274.
4. Artemov D, Mori N, Ravi R, and Bhujwalla ZM (2003). Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res 63, 2723-2727.
5. Kircher MF, Josephson L, and Weissleder R (2002). Ratio imaging of enzyme activity using dual wavelength optical reporters. Mol Imaging 1, 89-95.
6. Ray P, Wu AM, and Gambhir SS (2003). Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice. Cancer Res 63, 1160-1165.
7. Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, Jacobs RE, Fraser SE, and Meade TJ (2000). In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 18, 321-325.
8. Brosnan MJ, Raman SP, Chen L, and Koretsky AP (1993). Altering creatine kinase isoenzymes in transgenic mouse muscle by overexpression of the B subunit. Am J Physiol 264, C151-160.
9. Stegman LD, Rehemtulla A, Beattie B, Kievit E, Lawrence TS, Blasberg RG, Tjuvajev JG, and Ross BD (1999). Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc Natl Acad Sci USA 96, 9821-9826.
10. Weissleder R, Simonova M, Bogdanova A, Bredow S, Enochs WS, and Bogdanov A Jr (1997). MR imaging and scintigraphy of gene expression through melanin induction. Radiology 204, 425-429.
11. Alfke H, Stoppler H, Nocken F, Heverhagen JT, Kleb B, Czubayko F, and Klose KJ (2003). In vitro MR imaging of regulated gene expression. Radiology 228, 488-492.
12. Crichton RR, Wilmet S, Legssyer R, and Ward RJ (2002). Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem 91, 9-18.
13. Harrison PM and Arosio P (1996). The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275, 161-203.
14. Treffry A, Zhao Z, Quail MA, Guest JR, and Harrison PM (1997). Dinuclear center of ferritin: studies of iron binding and oxidation show differences in the two iron sites. Biochemistry 36, 432-441.
15. Hempstead PD, Yewdall SJ, Fernie AR, Lawson DM, Artymiuk PJ, Rice DW, Ford GC, and Harrison PM (1997). Comparison of the three-dimensional structures of recombinant human H and horse L ferritins at high resolution. J Mol Biol 268, 424-448.
16. Cozzi A, Corsi B, Levi S, Santambrogio P, Albertini A, and Arosio P (2000). Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem 275, 25122-25129.
17. Argyropoulou MI, Kiortsis DN, and Efremidis SC (2003). MRI of the liver and the pituitary gland in patients with beta-thalassemia major: does hepatic siderosis predict pituitary iron deposition? Eur Radiol 13, 12-16.
18. Bartzokis G and Tishler TA (2000). MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. Cell Mol Biol (Noisy-le-Grand) 46, 821-833.
19. Gottesfeld Z and Neeman M (1996). Ferritin effect on the transverse relaxation of water: NMR microscopy at 9.4 T. Magn Reson Med 35, 514-520.
20. Herynek V, Bulte JW, Douglas T, and Brooks RA (2000). Dynamic relaxometry: application to iron uptake by ferritin. J Biol Inorg Chem 5, 51-56.
21. Borenfreund EPJ (1986). Cytotoxicity of metals, metal-metal and metal-chelator combinations assayed in vitro. Toxicology 39, 121-134.
22. Du YP, Parker DL, Davis WL, and Cao G (1994). Reduction of partial-volume artifacts with zero-filled interpolation in three-dimensional MR angiography. J Magn Reson Imaging 4, 733-741.
23. Bauminger ER, Harrison PM, Hechel D, Hudson NW, Nowik I, Treffry A, and Yewdall SJ (1993). Iron (II) oxidation and early intermediates of iron-core formation in recombinant human H-chain ferritin. Biochem J 296 (Part 3), 709-719.
24. Gossuin Y, Roch A, Muller RN, Gillis P, and Lo Bue F (2002). Anomalous nuclear magnetic relaxation of aqueous solutions of ferritin: an unprecedented first-order mechanism. Magn Reson Med 48, 959-964.
25. Vymazal J, Brooks RA, Bulte JW, Gordon D, and Aisen P (1998). Iron uptake by ferritin: NMR relaxometry studies at low iron loads. J Inorg Biochem 71, 153-157.
26. Vymazal J, Zak O, Bulte JW, Aisen P, and Brooks RA (1996). T1 and T2 of ferritin solutions: effect of loading factor. Magn Reson Med 36, 61-65.
27. Bauminger ER, Treffry A, Hudson AJ, Hechel D, Hodson NW, Andrews S, Levi S, Nowik I, Arosio P, et al. (1994). Iron incorporation into ferritins: evidence for the transfer of monomeric Fe(III) between ferritin molecules and for the formation of an unusual mineral in the ferritin of Escherichia coli. Biochem J 302 (Part 3), 813-820.
28. Wood JC, Fassler JD, and Meade T (2004). Mimicking liver iron overload using liposomal ferritin preparations. Magn Reson Med 51, 607-611.
29. Bartzokis G, Aravagiri M, Oldendorf WH, Mintz J, and Marder SR (1993). Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med 29, 459-464.
30. Rouault T and Klausner R (1997). Regulation of iron metabolism in eukaryotes. Curr Top Cell Regul 35, 1-19.
31. Klausner RD, Rouault TA, and Harford JB (1993). Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72, 19-28.
32. Theil EC (2003). Ferritin: at the crossroads of iron and oxygen metabolism. J Nutr 133, 1549S-1553S.
33. Picard V, Renaudie F, Porcher C, Hentze MW, Grandchamp B, and Beaumont C (1996). Overexpression of the ferritin H subunit in cultured erythroid cells changes the intracellular iron distribution. Blood 87, 2057-2064.